ANXA1 and neoplasm: Interestingly, in oesophageal cancer, ANXA1 levels were reportedly lower in moderately and poorly differentiated tumours in comparison to well-differentiated types and levels were downregulated particularly at the transitional switch between dysplastic to invasive tumours suggesting that ANXA1 could act as an early indicator for cancer progression [90,98].